Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 135

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 135
---
 our as adjusted net tangible book would have been
$357,000 or $0.13 per share of Common Stock.

After giving effect to the
receipt of the net proceeds from our sale of Common Stock in this offering at a public offering price of $1.96 per share of Common Stock,
assuming full exercise of the Pre-Funded Warrants sold in this offering, but no exercise of Offered Common Warrants, and after deducting
placement agent fees and estimated offering expenses payable by us, our pro forma net tangible book value as of September 30, 2024, would
have been $0.85 per share of Common Stock. This represents an immediate increase in net tangible book value of $0.72 per share of Common
Stock to our existing shareholders compared to our as adjusted net tangible book value per share and immediate dilution in net tangible
book value per share of $1.11 per share of Common Stock to investors purchasing Common Stock in this offering on such basis.

The following table illustrates this dilution
on a per share of Common Stock basis, assuming all shares of common stock outstanding as of September 30, 2024:

| Public offering price per share of Common Stock                                                                                
 Historical net tangible book value per share of Common Stock as of September 30, 2024                                          |     |   | (2.48 | ) |     |   |  1.96 |   |
|:-------------------------------------------------------------------------------------------------------------------------------|:----|:--|------:|:--|:----|:--|------:|:--|
| Increase (decrease) in net tangible book value per share of Common Stock resulting from subsequent transactions                |     |   |  2.61 |   |     |   |       |   |
| As adjusted net tangible book value per share of Common Stock as of September 30, 2024                                         |     |   |  0.13 |   |     |   |       |   |
| Increase in net tangible book value per share of Common Stock attributed to investors purchasing Common Stock in this offering |     | $ |  0.72 |   |     |   |       |   |
| Pro forma net tangible book value per share of Common Stock after this offering                                                |     |   |       |   |     | $ |  0.85 |   |
| Immediate dilution in net tangible book value per share of Common Stock to investors in this offering                          |     |   |